Skip to content
Recall Observatory FDA recall evidence

Drug product

diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC. Peapack, NJ 07977

D-0150-2018

October 20, 2017

Class I

Product summary

Firm
Pfizer Inc.
Event
Event 78332
Status
Terminated
Classification
Class I
Quantity
183437 bottles
Official record key
drug-enforcement:D-0150-2018

Official wording

Reason: SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Code information: Lots: a) R83962, R93347, R93348, R93349, R93350, R93351, R93352, Exp. 2021 OCT 31; S57831, S57832, S57834, Exp. 2021 NOV 30 b) R93356, R93357, R93358, R97310, Exp. 2021 OCT 31.

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    SUPERPOTENT